Digene Corp. of Gaithersburg will pay a New York biotechnology company at least $30.5 million to settle a patent-infringement lawsuit involving technology used in its leading product, the only ...
Shares of Digene, a maker of DNA and RNA tests, sizzled on Monday after it announced that Netherlands-based Qiagen would purchase the company in a $1.6 billion deal. Digene is best known for a test to ...
Digene Gel is an over-the-counter antacid medication used to relieve symptoms associated with acidity, heartburn, and indigestion. This type of antacid is taken orally and works by neutralizing excess ...
When federal regulators last week approved Digene Corp.'s cervical cancer test as a primary screening tool for women over 30, they catapulted what had been a follow-up test into direct competition ...
QIAGEN N.V. has announced the successful completion of its acquisition of Digene Corporation. QIAGEN completed the acquisition through a tender offer and subsequent merger of Digene with and into a ...
Deal consolidates firms’ technology in molecular diagnostics. Qiagen and Digene entered into a definitive agreement to combine the two companies to create market and technology leadership in molecular ...
Marissa Jaret Winokur‘s journey to motherhood is not typical and she wants to make sure that yours doesn’t go the same way. In 2000, at the age of 27, just as her Broadway career was starting to ...
Digene Corp. announced yesterday that Daryl J. Faulkner, a biotech industry veteran, will take over as chief executive next month. Faulkner replaces the Gaithersburg company’s current CEO, Evan L.
Qiagen, a Dutch maker of tools for gene research, has agreed to buy the Digene Corporation for $1.6 billion in shares and cash to gain tests for a virus that causes cervical cancer and sexually ...
New York Times subscribers* enjoy full access to TimesMachine—view over 150 years of New York Times journalism, as it originally appeared. *Does not include Games-only or Cooking-only subscribers. The ...
What: Daryl Faulkner, Chief Executive Officer of Digene Corporation (DIGE), will preside over the opening bell in honor of "Cervical Cancer Screening Month." Where: NASDAQ MarketSite - 4 Times Square ...
The diagnostic firm Digene Corp. is raising $56 million in gross proceeds by way of a public offering announced after Wednesday's market close. Management at the Gaithersburg, Md.-based company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results